56 results
Page 2 of 3
8-K
EX-99.1
zns4wtg69xqxp
3 May 22
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
u1ois n1je7lmyh7tnb
9 Feb 22
Results of Operations and Financial Condition
7:00am
8-K
EX-4.2
s9oor
10 Nov 21
Entry into a Material Definitive Agreement
4:31pm
8-K
05z 24eiion48ugg
10 Nov 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-4.6
n2tmgwqyzzw8kkqxhvm
10 Nov 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-5.2
qz53z88krhljbj83
10 Nov 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-5.1
2x5ld0n3 7t5t
10 Nov 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-5.3
5f47ahej78 9jdecxt
10 Nov 21
Entry into a Material Definitive Agreement
4:31pm
8-K
46vmfho8
4 Nov 21
Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5,000,000,000 of Sustainability-Linked Senior Notes
4:44pm
8-K
EX-1.1
utufdkf
4 Nov 21
Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5,000,000,000 of Sustainability-Linked Senior Notes
4:44pm
8-K
EX-99.1
0ioextk7prst3dmd
4 Nov 21
Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5,000,000,000 of Sustainability-Linked Senior Notes
4:44pm
424B5
zxxy2
4 Nov 21
Prospectus supplement for primary offering
4:41pm
FWP
ms9q3uaayk yg5pmx8
2 Nov 21
Free writing prospectus
5:29pm
424B3
n8vssy9 f7s2um6y4
27 Oct 21
Prospectus supplement
8:51am
S-3ASR
eo7rbc3lgzkvawz5up7g
27 Oct 21
Automatic shelf registration
7:42am